脂质过氧化通过激活TMEM16A驱动肾囊肿生长
该研究利用常染色体显性多囊肾患者组织、胚胎肾培养和MDCK体外囊肿模型,发现活性氧增强导致膜磷脂过氧化,后者激活TMEM16A氯通道并耗竭钙库,促进囊肿生长;清除活性氧或抑制脂质过氧化可减少TMEM16A激活,抑制TMEM16A可减少增殖和液体分泌。
要点
- 脂质过氧化激活TMEM16A氯通道驱动囊肿生长。
- 活性氧清除剂或铁抑素-1可减少TMEM16A激活。
- 抑制TMEM16A或脂质过氧化可能延缓PKD囊肿发展。
核心结论
- 脂质过氧化激活TMEM16A驱动肾囊肿生长,直接抑制TMEM16A或抑制脂质过氧化可能是延缓PKD囊肿发展的治疗策略。
研究设计与样本
- 使用常染色体显性多囊肾患者组织样本、胚胎肾培养和MDCK体外囊肿模型,结合Ussing室和膜片钳电生理实验分析TMEM16A激活与囊肿生长。
主要发现
- 人和小鼠多囊肾及MDCK囊肿中磷脂过氧化可能由活性氧水平增强所致。
- 脂质过氧化与肾培养和MDCK三维培养中囊肿体积增加相关。
- 活性氧和脂质过氧化强烈激活TMEM16A,导致钙库耗竭和钙库操纵性钙内流。
- TMEM16A和CFTR依赖的氯分泌激活强烈增强囊肿生长。
- 谷胱甘肽、辅酶Q10、艾地苯醌及铁抑素-1可大幅减少TMEM16A激活,抑制TMEM16A减少体外增殖和液体分泌。
临床怎么用
- 提示直接抑制TMEM16A或抑制脂质过氧化可能作为延缓PKD囊肿发展的潜在治疗途径。
局限性
- 研究主要基于体外模型和患者组织样本,未报告临床干预数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transepithelial chloride- secretion, through the chloride channels cystic fibrosis transmembrane conductance regulator (CFTR) and TMEM16A (anoctamin 1), drives cyst enlargement in polycystic kidney disease (PKD). Polycystic kidneys are hypoxic, and oxidative stress activates TMEM16A. However, mechanisms for channel activation in PKD remain obscure. METHODS: Using tissue samples from patients with autosomal dominant PKD, embryonic kidney cultures, and an MDCK in vitro cyst model, we assessed peroxidation of plasma membrane phospholipids in human and mouse polycystic kidneys. We also used electrophysiologic Ussing chamber and patch clamp experiments to analyze activation of TMEM16A and growth of renal cysts. RESULTS: Peroxidation of phospholipids in human and mouse kidneys as well as MDCK cysts in vitro is probably due to enhanced levels of reactive oxygen species. Lipid peroxidation correlated with increased cyst volume as shown in renal cultures and MDCK cysts in three-dimensional cultures. Reactive oxygen species and lipid peroxidation strongly activated TMEM16A, leading to depletion of calcium ion stores and store-operated calcium influx. Activation of TMEM16A- and CFTR-dependent chloride secretion strongly augmented cyst growth. Exposure to scavengers of reactive oxygen species, such as glutathione, coenzyme Q10, or idebenone (a synthetic coenzyme Q10 homolog), as well as inhibition of oxidative lipid damage by ferrostatin-1 largely reduced activation of TMEM16A. Inhibition of TMEM16A reduced proliferation and fluid secretion in vitro. CONCLUSIONS: These findings indicate that activation of TMEM16A by lipid peroxidation drives growth of renal cysts. We propose direct inhibition of TMEM16A or inhibition of lipid peroxidation as potentially powerful therapeutic approaches to delay cyst development in PKD.
引用
- Schreiber R, Buchholz B, Kraus A, et al. Lipid Peroxidation Drives Renal Cyst Growth In Vitro through Activation of TMEM16A. J Am Soc Nephrol. 2019. PMID: 30606785. doi:10.1681/ASN.2018010039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。